SCHEMBL23488259

SCHEMBL23488259

NC(=O)c1ccc(OCc2ccccc2)nc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 2/20 0.62
OPRK1 P41145 7/20 0.60
OPRM1 P35372 7/20 0.60
OPRD1 P41143 6/20 0.60
NNMT P40261 2/20 0.57
CXCR2 P25025 1/20 0.56
KCNH2 Q12809 2/20 0.54
GRIN2D O15399 1/20 0.54
GRIN3B O60391 1/20 0.54
SLC6A2 P23975 1/20 0.54
SLC6A3 Q01959 1/20 0.54
GRIN1 Q05586 1/20 0.54
GRIN2A Q12879 1/20 0.54
GRIN2B Q13224 1/20 0.54
ROCK1 Q13464 1/20 0.54
GRIN2C Q14957 1/20 0.54
GRIN3A Q8TCU5 1/20 0.54
CHRNB2 P17787 1/20 0.50
CHRNA7 P36544 1/20 0.50
CHRNA4 P43681 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1221922 0.87 MAPT (0.63) CXCR2CHRNB2CHRNA7CHRNA4
SCHEMBL23488401 0.85 SIRT2 (0.53) PARP10OPRK1OPRM1OPRD1NNMT
SCHEMBL1091737 0.84 MAOB (0.62) PARP10CXCR2CHRNB2CHRNA7CHRNA4
SCHEMBL20830743 0.83 CHRNB2 (0.61) CXCR2SLC6A2SLC6A3CHRNB2CHRNA7
SCHEMBL27888270 0.82 CXCR2 (0.52) PARP10OPRK1OPRM1OPRD1CXCR2
SCHEMBL3506490 0.82 CXCR2 (0.49) PARP10OPRK1OPRM1OPRD1NNMT
SCHEMBL3506489 0.82 SPHK2 (0.62) PARP10OPRK1OPRM1OPRD1CXCR2
SCHEMBL28703922 0.82 CXCR2 (0.64) CXCR2CHRNB2CHRNA7CHRNA4
Nitrous Acid SCHEMBL27888273 0.82 MAPT (0.56) CXCR2CHRNB2CHRNA7CHRNA4
SCHEMBL246555 0.82 GABRA5 (0.60) CXCR2CHRNB2CHRNA7CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 PARP10 1135/4885OPRK1 3313/4885OPRM1 3557/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.